Trial · NCT02563002
Participant flow12
How many started, completed or left each group, period by period.
1 to 12 of 12
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Pembrolizumab | 153 | |
| Overall Study | STARTED | Standard of Care (SOC) | 154 | |
| Overall Study | Treated | Pembrolizumab | 153 | |
| Overall Study | Treated | Standard of Care (SOC) | 143 | |
| Overall Study | Received Second Course of Pembrolizumab | Pembrolizumab | 12 | |
| Overall Study | Received Second Course of Pembrolizumab | Standard of Care (SOC) | 5 | |
| Overall Study | Switched Over to Pembrolizumab | Pembrolizumab | 0 | |
| Overall Study | Switched Over to Pembrolizumab | Standard of Care (SOC) | 7 | |
| Overall Study | COMPLETED | Pembrolizumab | 0 | |
| Overall Study | COMPLETED | Standard of Care (SOC) | 0 | |
| Overall Study | NOT COMPLETED | Pembrolizumab | 153 | |
| Overall Study | NOT COMPLETED | Standard of Care (SOC) | 154 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02563002/flow